U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
139594
Name Type Language
EBRONUCIMAB
INN  
Official Name English
Ebronucimab [WHO-DD]
Common Name English
IMMUNOGLOBULIN G1-LAMBDA2, ANTI-(HOMO SAPIENS PCSK9 (PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9, NEURAL APOPTOSIS-REGULATED CONVERTASE 1, NARC1, NARC-1, PROPROTEIN CONVERTASE 9, PC9)), HOMO SAPIENS MONOCLONAL ANTIBODY
Common Name English
IMMUNOGLOBULIN G1, ANTI-(HUMAN NEURAL APOPTOSIS-REGULATED CONVERTASE 1) (HUMAN MONOCLONAL AK102 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL AK102 .LAMBDA.-CHAIN, DIMER
Common Name English
ebronucimab [INN]
Common Name English
Code System Code Type Description
INN
11476
Created by admin on Sat Dec 16 16:23:20 GMT 2023 , Edited by admin on Sat Dec 16 16:23:20 GMT 2023
PRIMARY
NCI_THESAURUS
C175774
Created by admin on Sat Dec 16 16:23:20 GMT 2023 , Edited by admin on Sat Dec 16 16:23:20 GMT 2023
PRIMARY
FDA UNII
CXX4Q31AAO
Created by admin on Sat Dec 16 16:23:20 GMT 2023 , Edited by admin on Sat Dec 16 16:23:20 GMT 2023
PRIMARY
CAS
2304800-90-4
Created by admin on Sat Dec 16 16:23:20 GMT 2023 , Edited by admin on Sat Dec 16 16:23:20 GMT 2023
PRIMARY
ACTIVE MOIETY
EBRONUCIMAB
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966